Monday, 22 Jan 2018

You are here

Bone Marrow Edema May be Found in Normals, Athletes and Military Recruits

Rheumatology has published a study demonstrating that bone marrow edema as measured by magnetic resonance imaging (MRI) may be found in healthy people, but that such changes do not change with intense physical activity. (Citation source https://buff.ly/2CvbuXD)

These findings are notable in light of recent reports from the ACR 2017 meeting showing that bone marrow edema was  commonly seen in the SI joints of athletes (Abstract #1830) and that MRI evidence of bone marrow edema in the SI joints is not specific for axial spondyloarthritis  (Abstract #1831).

In the current observational study, 22 military recruits underwent an MRI of the SI joints before and after 6 weeks of intense standardized physical training. Bone marrow edema and structural lesions were scored based on the Spondyloarthritis Research Consortium of Canada (SPARCC) method. 

At the beginning, 40.9% of recruits already presented a SPARCC score indicating bone marrow edema; this number showed a nonsigificant increase to 50% after six weeks.  Similarly, the number of positive MRI by ASAS definition was not significantly different in the two time points. 

They found no relationship between symptoms of back pain and bone marrow edema lesions.

The study underscores the necessity to interpret MRI findings of the sacroiliac joints in the appropriate clinical context, even in a young active population.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Weight Loss Linked to RA Improvement

By retrospectively reviewing electronic health record (EHR) data, Kreps et al found that rheumatoid arthritis (RA) patients who lost >5 kg of weight were three times more likely to demonstrate improvement in disease activity.

Researchers investigated the association between weight loss and CDAI change among patients who were overweight/obese at baseline and who lost weight during follow-up.

IL-1 and IL-6 Inhibition Preferred in Systemic JIA

Since 2000, the German Biologics register (BiKeR) has prospectively enrolled children with juvenile idiopathic arthritis to assess outcomes with biologic therapies.  A new report evaluates the efficacy and safety of etanercept (ETA), tocilizumab (TOC) and the interleukin-1 inhibitors (anakinra and canakinumab) (IL-1i) in those with systemic onset juvenile idiopathic arthritis JIA (sJIA).

Increasing Adverse Events Seen with Higher Disease Activity in Early RA

Researchers in the NEO-RACo Study Group studied adverse events (AEs) in relation to disease activity in patients with early rheumatoid arthritis (RA).

Small Joint Surgeries Drop Among RA Patients

The rate of small - but not large - joint surgery has dropped among patients with rheumatoid arthritis since 1995, a retrospective review of orthopedic surgeries found. By 2015, less than 1% of patients per year underwent small joint surgery, reported Ashima Makol, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues in Arthritis Care & Research. 

Despite Increasing Metric Use, They Are Not Widespread in Rheumatoid Care

The Journal of Rheumatology has published a nationwide survey of US rheumatologists and shown that despite trends for increasing metric assessments, nearly half of rheumatoid arthritis (RA) patients are not routinely assessed with a disease activity metric and the evidence they use these in a treat-to-target (T2T) practice is lacking.